164 related articles for article (PubMed ID: 35675421)
41. Long non-coding RNA CASC2 regulates Sprouty2 via functioning as a competing endogenous RNA for miR-183 to modulate the sensitivity of prostate cancer cells to docetaxel.
Gao W; Lin S; Cheng C; Zhu A; Hu Y; Shi Z; Zhang X; Hong Z
Arch Biochem Biophys; 2019 Apr; 665():69-78. PubMed ID: 29373811
[TBL] [Abstract][Full Text] [Related]
42. HIF-Dependent CKB Expression Promotes Breast Cancer Metastasis, Whereas Cyclocreatine Therapy Impairs Cellular Invasion and Improves Chemotherapy Efficacy.
Krutilina RI; Playa H; Brooks DL; Schwab LP; Parke DN; Oluwalana D; Layman DR; Fan M; Johnson DL; Yue J; Smallwood H; Seagroves TN
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008190
[TBL] [Abstract][Full Text] [Related]
43. Utilization of cyclocreatine phosphate, and analogue of creatine phosphate, by mouse brain during ischemia and its sparing action on brain energy reserves.
Woznicki DT; Walker JB
J Neurochem; 1980 May; 34(5):1247-53. PubMed ID: 7373304
[No Abstract] [Full Text] [Related]
44. Enhanced ability of skeletal muscle containing cyclocreatine phosphate to sustain ATP levels during ischemia following beta-adrenergic stimulation.
Turner DM; Walker JB
J Biol Chem; 1987 May; 262(14):6605-9. PubMed ID: 3571272
[TBL] [Abstract][Full Text] [Related]
45. Free ADP levels in transgenic mouse liver expressing creatine kinase. Effects of enzyme activity, phosphagen type, and substrate concentration.
Brosnan MJ; Chen L; Van Dyke TA; Koretsky AP
J Biol Chem; 1990 Dec; 265(34):20849-55. PubMed ID: 2249991
[TBL] [Abstract][Full Text] [Related]
46. Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function.
Berglund AE; Scott KE; Li W; Yang C; Fernandez MR; Schaub FX; Cleveland JL; Rounbehler RJ
Oncotarget; 2016 Dec; 7(50):83462-83475. PubMed ID: 27825143
[TBL] [Abstract][Full Text] [Related]
47. Knockdown of GSG2 inhibits prostate cancer progression in vitro and in vivo.
Yu F; Lin Y; Xu X; Liu W; Tang D; Zhou X; Wang G; Zheng Y; Xie A
Int J Oncol; 2020 Jul; 57(1):139-150. PubMed ID: 32319597
[TBL] [Abstract][Full Text] [Related]
48. Atg7 cooperates with Pten loss to drive prostate cancer tumor growth.
Santanam U; Banach-Petrosky W; Abate-Shen C; Shen MM; White E; DiPaola RS
Genes Dev; 2016 Feb; 30(4):399-407. PubMed ID: 26883359
[TBL] [Abstract][Full Text] [Related]
49. A Mouse Model of Creatine Transporter Deficiency Reveals Impaired Motor Function and Muscle Energy Metabolism.
Stockebrand M; Sasani A; Das D; Hornig S; Hermans-Borgmeyer I; Lake HA; Isbrandt D; Lygate CA; Heerschap A; Neu A; Choe CU
Front Physiol; 2018; 9():773. PubMed ID: 30013483
[TBL] [Abstract][Full Text] [Related]
50. A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling.
Esmaeili M; Pungsrinont T; Schaefer A; Baniahmad A
J Mol Med (Berl); 2016 Oct; 94(10):1167-1179. PubMed ID: 27305909
[TBL] [Abstract][Full Text] [Related]
51. New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells.
Lai KP; Huang CK; Chang YJ; Chung CY; Yamashita S; Li L; Lee SO; Yeh S; Chang C
Am J Pathol; 2013 Feb; 182(2):460-73. PubMed ID: 23219429
[TBL] [Abstract][Full Text] [Related]
52. Cyclocreatine transport and cytotoxicity in rat glioma and human ovarian carcinoma cells: 31P-NMR spectroscopy.
Schiffenbauer YS; Meir G; Cohn M; Neeman M
Am J Physiol; 1996 Jan; 270(1 Pt 1):C160-9. PubMed ID: 8772441
[TBL] [Abstract][Full Text] [Related]
53. Modelling synergistic interactions between HER2, Sprouty2 and PTEN in driving prostate carcinogenesis.
Ahmad I; Gao M; Patel R; Leung HY
Asian J Androl; 2013 May; 15(3):323-7. PubMed ID: 23584380
[No Abstract] [Full Text] [Related]
54. Sprouty2 enhances the tumorigenic potential of glioblastoma cells.
Park JW; Wollmann G; Urbiola C; Fogli B; Florio T; Geley S; Klimaschewski L
Neuro Oncol; 2018 Jul; 20(8):1044-1054. PubMed ID: 29635363
[TBL] [Abstract][Full Text] [Related]
55. High-performance liquid chromatographic assays for free and phosphorylated derivatives of the creatine analogues beta-guanidopropionic acid and 1-carboxy-methyl-2-iminoimidazolidine (cyclocreatine).
Wiseman RW; Moerland TS; Chase PB; Stuppard R; Kushmerick MJ
Anal Biochem; 1992 Aug; 204(2):383-9. PubMed ID: 1443539
[TBL] [Abstract][Full Text] [Related]
56. Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis.
Kornacker M; Schlattner U; Wallimann T; Verneris MR; Negrin RS; Kornacker B; Staratschek-Jox A; Diehl V; Wolf J
Int J Cancer; 2001 Nov; 94(4):513-9. PubMed ID: 11745437
[TBL] [Abstract][Full Text] [Related]
57. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
[TBL] [Abstract][Full Text] [Related]
58. Sprouty2 regulates proliferation and survival of multiple myeloma by inhibiting activation of the ERK1/2 pathway in vitro and in vivo.
Yao Y; Luo J; Bian Y; Sun Y; Shi M; Xia D; Niu M; Zhao K; Zeng L; Chen W; Li Z; Xu K
Exp Hematol; 2016 Jun; 44(6):474-482.e2. PubMed ID: 27016275
[TBL] [Abstract][Full Text] [Related]
59. Cloning and characterization of the promoter regions from the parent and paralogous creatine transporter genes.
Ndika JD; Lusink V; Beaubrun C; Kanhai W; Martinez-Munoz C; Jakobs C; Salomons GS
Gene; 2014 Jan; 533(2):488-93. PubMed ID: 24144841
[TBL] [Abstract][Full Text] [Related]
60. Effects of amide creatine derivatives in brain hippocampal slices, and their possible usefulness for curing creatine transporter deficiency.
Garbati P; Adriano E; Salis A; Ravera S; Damonte G; Millo E; Balestrino M
Neurochem Res; 2014 Jan; 39(1):37-45. PubMed ID: 24213972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
